RxDoctor Payments Data

Sam Kashani, MD

Sleep Medicine · Santa Monica, CANPI 1447639869

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $161,980 of the $221,342 with a category attached, or 73.2%. 13 manufacturers reported payments, led by Jazz Pharmaceuticals Inc. at 53.5% of the total. 2025 is the largest year on record at $117,027, more than ten times the $190 reported in 2021. Among sleep medicine clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$221,342in general payments, 2019–2025

Across 255 payments — averaging $868.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$118K
  • Avadel CNS Pharmaceuticals, LLC$55K
  • Harmony Biosciences LLC$26K
  • Axsome Therapeutics, Inc.$20K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • Inspire Medical Systems, Inc.$291
  • plus $499 from 7 others

What the payments were for

  • Consulting fees$22,99010%
  • Speaking & faculty fees$161,98073%
  • Travel & lodging$27,63912%
  • Food & beverage$8,4714%
  • Education$2620%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$221,342 in reported general payments places this provider in the 95th percentile of 200 sleep medicine providers in California.

See all sleep medicine providers in California

Medicare billing

Part B allowed, 2024
$128,327
Medicare patients
422
Services billed
894

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelsomraSuvorexant26$13,127
Zolpidem Tartrate87$1,660
Doxepin Hcl11$969
Eszopiclone40$529
Zolpidem Tartrate ErZolpidem Tartrate21$467
Fluticasone Propionate25$255
Gabapentin33$244

Paid to pharmacies, not to this prescriber.

Other sleep medicine in Santa Monica

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →